摘要
目的探讨经尿道柱状水囊前列腺扩开术治疗高危前列腺增生患者的临床疗效。方法回顾性分析2016年6月至2018年7月我科收治的50例高危前列腺增生患者的临床资料,分成治疗组23例,对照组27例,治疗组采用新手术方式经尿道柱状水囊前列腺扩开术治疗。对照组采用经尿道前列腺等离子电切术,比较两组的手术时间、血红蛋白丢失量、持续膀胱冲洗时间、导尿管留置时间、并发症发生率及术后住院时间。术后随访观察比较两组生活质量评分(QOL)、国际前列腺症状评分(IPSS),最大尿流率(Qmax)、残余尿(RUV)等指标。结果手术均获成功,治疗组平均手术时间较对照组短[(16±4)min vs(97±11)min,P=0.001],手术组血红蛋白丢失量较对照组少[(19±4)g/L vs(75±8)g/L,P=0.017],持续膀胱冲洗时间较对照组缩短[(1.21±0.14)d vs(3.77±0.52)d,P=0.046],但导尿管留置时间和术后住院时间均高于对照组。术后随访3~12个月,QOL、IPSS、Qmax、RUV与对照组比较差异无统计学意义(P>0.05)。结论经尿道柱状水囊前列腺扩开术治疗前列腺增生,操作便捷、创伤小,手术时间短,对于高危前列腺增生患者,可以有限推广。
Objective To investigate the clinical efficacy of transurethral columnar balloon dilation of prostate for high-risk patients with benign prostatic hyperplasia(BPH).Methods The data of 50 high-risk BPH patients admitted to our department From June 2016 to July 2018 were analyzed retrospectively.The patients were divided into the treatment group(23 cases)and the control group(27 cases).Transurethral columnar balloon dilation of prostate was performed in the treatment group,and transurethral plasma kinetic resection of prostate was performed in the control group.The operation time,intraoperative hemoglobin loss,continuous bladder irrigation time,catheter retention time,complication rate and the length of postoperative hospitalization were compared between the two groups.The postoperative quality of life(QOL),the international prostate symptom score(IPSS),maximum urinary flow rate(Qmax)and residual urine volume(RUV)were compared.Result All patients were operated successfully.The average operation time in the treatment group was shorter than that of the control group[(16±4)min vs(97±11)min,P=0.001].The loss of hemoglobin in the treatment group was less than that of the control group[(19±4)g/L vs(75±8)g/L,P=0.017],and the continuous bladder irrigation time was shorter than that of the control group[(1.21±0.14)d vs(3.77±0.52)d,P=0.046].However,the length of catheter retention and postoperative hospitalization in the treatment group were longer than those in the control group.There was no difference in the post-operative QOL,IPSS,Qmax and RUV during 3 to 12 months follow-up.Conclusion Transurethral columnar balloon dilation of prostate is an effective supplement for the treatment of high-risk BPH patients as a result of short operation time,less hemoglobin loss and optimized operation process.
作者
张翼飞
张华
尹水平
梁朝朝
Zhang Yifei;Zhang hua;Yin Shuiping;Liang Chaozhao(Department of Urology,the First Affiliated Hospital of Anhui Medical University,Hefei 230022,China;Department of Urology,Taihe County Hospital,Anhui Fuyang 236600,China)
出处
《中华腔镜泌尿外科杂志（电子版）》
2021年第2期144-147,共4页
Chinese Journal of Endourology(Electronic Edition)
关键词
前列腺增生
柱状水囊
前列腺扩开术
高危患者
Benign prostatic hyperplasia
Columnar balloon
Dilation of prostate
Highrisk patients
